Drug Shortage Report for APO-NALTREXONE

Last updated on 2021-03-15 History
Report ID 133991
Drug Identification Number 02444275
Brand name APO-NALTREXONE
Common or Proper name NALTREXONE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NALTREXONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 BTL
ATC code N07BB
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-11
Estimated end date 2021-04-02
Actual end date 2021-03-12
Shortage status Resolved
Updated date 2021-03-15
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-03-15 French Compare
v3 2021-03-15 English Compare
v2 2021-02-12 French Compare
v1 2021-02-12 English Compare